Search company, investor...


Founded Year



Grant | Alive

Total Raised


Last Raised

$4M | 13 yrs ago

About AllTranz

AllTranz aims to provide relief from chronic pain to patients outside the hospital setting.

Headquarters Location

2277 Thunderstick Drive

Lexington, Kentucky, 40505,

United States


Missing: AllTranz's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AllTranz's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

AllTranz Patents

AllTranz has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Prodrugs, Morphinans, Phenols, Semisynthetic opioids, Dosage forms


Application Date


Grant Date



Related Topics

Prodrugs, Morphinans, Phenols, Semisynthetic opioids, Dosage forms



AllTranz Frequently Asked Questions (FAQ)

  • When was AllTranz founded?

    AllTranz was founded in 2004.

  • Where is AllTranz's headquarters?

    AllTranz's headquarters is located at 2277 Thunderstick Drive, Lexington.

  • What is AllTranz's latest funding round?

    AllTranz's latest funding round is Grant.

  • How much did AllTranz raise?

    AllTranz raised a total of $4.86M.

  • Who are the investors of AllTranz?

    Investors of AllTranz include National Institute on Drug Abuse, Kentucky Seed Capital Fund, Commonwealth Seed Capital and Bluegrass Angels.

  • Who are AllTranz's competitors?

    Competitors of AllTranz include BioWave, Relievant Medsystems, eNeura Therapeutics, Light Sciences Oncology, SteadyMed Therapeutics and 11 more.

Compare AllTranz to Competitors

BioWave Logo

BioWave is a neuromodulation pain therapy company whose major goal is to help physicians, physical therapists and athletic trainers manage their patients' or athletes pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. Biowave devices deliver a therapeutic electrical signal into deep tissue in the body blocking the transmission of pain.

Salutaris Medical Devices

Salutaris Medical Devices (SalutarisMD) is a clinical-stage medical device company developing an investigational ophthalmic treatment for Wet Age-related Macular Degeneration (Wet AMD). SalutarisMD is developing a minimally invasive procedure that can be performed in an outpatient or physician office setting in approximately 15 minutes.

Relievant Medsystems Logo
Relievant Medsystems

Relievant provides the underserved population with a low-risk therapy that can eliminate back pain while preserving other therapeutic options. The Company's Intracept System is a minimally invasive procedure that uses radiofrequency energy delivered through a small access tube into the vertebral body to ablate the Basivertebral nerve. The nerve, thought to significantly contribute to chronic low back pain, can no longer generate pain signals following ablation. The company was founded in 2004 and is based in Minneapolis, Minnesota.


Trigemina is focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products. Trigemina's lead product candidate, TI-001, is a patented new application of oxytocin. TI-001 has shown promising results for use as a safe and effective therapy for all forms of chronic and subacute head pain.

eNeura Therapeutics

eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.

KT Tape

2nd place finisher at the 2009 BYU Business Plan Competition. KT Tape brings kinesiology therapeutic tape directly to the consumers. The tape has the same elasticity as skin and relieves pain by lifting skin off of the injured location to increase circulation. KT Tape already has an exclusive endorsement from Kerri Walsh -- U.S. Olympic volleyball player who wore the tape at the Beijing Olympics

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.